Research map: Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance

Back to the article

Papers in this map

  1. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma · Richard S. Finn · 2020 · 7562 citations · Cited by this paper
  2. Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control · 2026 · Related
  3. WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers · Jason J. Luke · 2019 · 735 citations · Cited by this paper
  4. Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy · 2026 · Related
  5. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors · Yang Yang · 2018 · 318 citations · Cited by this paper
  6. AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer · 2026 · Related
  7. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer · Nicolas Reynoird · 2016 · 89 citations · Cited by this paper
  8. CART-immune-related adverse events after BCMA CAR-T therapy · 2026 · Related
  9. SMYD2 inhibition–mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity · Ming Tang · 2023 · 32 citations · Cited by this paper
  10. Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis · 2026 · Related
  11. SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis · Kangdi Xu · 2022 · 28 citations · Cited by this paper
  12. Synergistic Cell-Cycle Repression by HDAC/EZH2 Co-Targeting in H3K27-Altered Diffuse Midline Glioma · 2026 · Related
  13. Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity · 2026 · Related
  14. CAR design equips diverse immune cells with unique antigen-specific activation identities · 2026 · Related
  15. Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations · 2026 · Related
  16. Strategies to prevent HNSCC by chewing gum delivery of enzymes/antimicrobials to reduce carcinogenic acetaldehyde produced by pathogenic microbes · 2026 · Related

Source: OpenAlex (CC0)